41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL. - Chamuleau, M. E.; Wang, S.; Nijland, M.; Strobbe, L.; Oosterveld, M.; Boersma, R.; Koene, H.; Klerk, C. P.; de Jongh, E.; Koster, A.; Pruijt, H.; van der Poel, M.; et al. (Hematological oncology, 2025)